Get 20M+ Full-Text Papers For Less Than $1.50/day. Start a 14-Day Trial for You and Your Team.

Learn More →

Patterns and Trends in Antipsychotic Prescribing for Parkinson Disease Psychosis

Patterns and Trends in Antipsychotic Prescribing for Parkinson Disease Psychosis ORIGINAL CONTRIBUTION Patterns and Trends in Antipsychotic Prescribing for Parkinson Disease Psychosis Daniel Weintraub, MD; Peijun Chen, MD, PhD, MPH; Rosalinda V. Ignacio, MS; Eugenia Mamikonyan, MS; Helen C. Kales, MD Background: Antipsychotic (AP) use is common in Par- Main Outcome Measure: Antipsychotic prescribing, kinson disease (PD), but APs can worsen parkinsonism, including overall, class, and specific medications. evidence for efficacy is limited, and use in patients with dementia increases mortality. Results: In FY2008, 50% of patients with PD having a di- agnosis of psychosis were prescribed an AP. Among treated Objective: To examine the frequency and characteris- patients, the atypical AP quetiapine was most frequently tics, including changes over time, of AP use in a large prescribed (66%), but approximately 30% received high- cohort of patients with PD. potency APs. Clozapine was rarely prescribed (2%). In multivariate models, diagnoses of PD and dementia were Design: Using Veterans Affairs data from fiscal year associated with AP use. Comparing FY2008 with FY2002, (FY) 2008, rates and predictors of AP prescribing were AP use in PD was unchanged, with decreases in risperi- determined for patients with PD and psychosis stratified done and olanzapine use offset by an increase in quetiap- by http://www.deepdyve.com/assets/images/DeepDyve-Logo-lg.png JAMA Neurology American Medical Association

Patterns and Trends in Antipsychotic Prescribing for Parkinson Disease Psychosis

Loading next page...
 
/lp/american-medical-association/patterns-and-trends-in-antipsychotic-prescribing-for-parkinson-disease-0nC1JIRfYG
Publisher
American Medical Association
Copyright
Copyright 2011 American Medical Association. All Rights Reserved. Applicable FARS/DFARS Restrictions Apply to Government Use.
ISSN
2168-6149
eISSN
2168-6157
DOI
10.1001/archneurol.2011.139
pmid
21747029
Publisher site
See Article on Publisher Site

Abstract

ORIGINAL CONTRIBUTION Patterns and Trends in Antipsychotic Prescribing for Parkinson Disease Psychosis Daniel Weintraub, MD; Peijun Chen, MD, PhD, MPH; Rosalinda V. Ignacio, MS; Eugenia Mamikonyan, MS; Helen C. Kales, MD Background: Antipsychotic (AP) use is common in Par- Main Outcome Measure: Antipsychotic prescribing, kinson disease (PD), but APs can worsen parkinsonism, including overall, class, and specific medications. evidence for efficacy is limited, and use in patients with dementia increases mortality. Results: In FY2008, 50% of patients with PD having a di- agnosis of psychosis were prescribed an AP. Among treated Objective: To examine the frequency and characteris- patients, the atypical AP quetiapine was most frequently tics, including changes over time, of AP use in a large prescribed (66%), but approximately 30% received high- cohort of patients with PD. potency APs. Clozapine was rarely prescribed (2%). In multivariate models, diagnoses of PD and dementia were Design: Using Veterans Affairs data from fiscal year associated with AP use. Comparing FY2008 with FY2002, (FY) 2008, rates and predictors of AP prescribing were AP use in PD was unchanged, with decreases in risperi- determined for patients with PD and psychosis stratified done and olanzapine use offset by an increase in quetiap- by

Journal

JAMA NeurologyAmerican Medical Association

Published: Jul 1, 2011

References

You’re reading a free preview. Subscribe to read the entire article.


DeepDyve is your
personal research library

It’s your single place to instantly
discover and read the research
that matters to you.

Enjoy affordable access to
over 18 million articles from more than
15,000 peer-reviewed journals.

All for just $49/month

Explore the DeepDyve Library

Search

Query the DeepDyve database, plus search all of PubMed and Google Scholar seamlessly

Organize

Save any article or search result from DeepDyve, PubMed, and Google Scholar... all in one place.

Access

Get unlimited, online access to over 18 million full-text articles from more than 15,000 scientific journals.

Your journals are on DeepDyve

Read from thousands of the leading scholarly journals from SpringerNature, Wiley-Blackwell, Oxford University Press and more.

All the latest content is available, no embargo periods.

See the journals in your area

DeepDyve

Freelancer

DeepDyve

Pro

Price

FREE

$49/month
$499/year

Save searches from
Google Scholar,
PubMed

Create folders to
organize your research

Export folders, citations

Read DeepDyve articles

Abstract access only

Unlimited access to over
18 million full-text articles

Print

20 pages / month